$1.64+2.8%Nov 13 close
Reported results on November 13, 2026; they are not in these figures yet.
Figures through June 30, 2026, from the 10-Q filed August 7, 2026
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toSep 30, 2022 | Change |
|---|---|---|---|
| Total Revenue | $35M | $45K | +77,677.78% |
| Profit | $27.9M | -$6.9M | +505.66% |
| Profit per share | $0.89 | -$0.22 | +504.55% |
| Free Cash Flow | -$5.7M | -$8M | +29.04% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
The quote and the company description come from Actinium Pharmaceuticals, Inc.’s Item 2.02 8-K filed August 3, 2015; the table is built from its quarterly reports. Share prices are split- and dividend-adjusted.
Actinium Pharmaceuticals, Inc. reported on November 13, 2026. We are fetching the call transcript; its summary follows once the transcript is in.